The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
B7-H3/CD276: An Emerging Cancer Immunotherapy
Open accessAbstract
Immunotherapy aiming at suppressing tumor development by relying on modifying or strengthening the immune system prevails among cancer treatments and points out a new direction for cancer therapy. B7 homolog 3 protein (B7-H3, also known as CD276), a newly identified immunoregulatory protein member of the B7 family, is an attractive and promising target for cancer immunotherapy because it is overexpressed in tumor tissues while showing limited expression in normal tissues and participating in tumor microenvironment (TME) shaping and development. Thus far, numerous B7-H3-based immunotherapy strategies have demonstrated potent antitumor activity and acceptable safety profiles in preclinical models. Herein, we present the expression and biological function of B7-H3 in distinct cancer and normal cells, as well as B7-H3-mediated signal pathways in cancer cells and B7-H3-based tumor immunotherapy strategies. This review provides a comprehensive overview that encompasses B7-H3’s role in TME to its potential as a target in cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Sanmamed, M. F., & Chen, L. (2018) · Cell · doi:10.1016/j.cell.2018.09.035 · Cited by 1,392
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
Self-citationB7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G. L., Zhu, G., Tamada, K., et al. (2001) · Nature Immunology · doi:10.1038/85339 · Cited by 1,015
Molecular Basis of NF-κB Signaling
Napetschnig, J., & Wu, H. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130338 · Cited by 933
Majzner, R. G., Theruvath, J. L., Nellan, A., Heitzeneder, S., Cui, Y., Mount, C. W., Rietberg, S. P., Linde, M. H., Xu, P., Rota, C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0432 · Cited by 681
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2428 · Cited by 582
The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
Suh, W.-K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S., Bukczynski, J., Plyte, S., Elia, A., et al. (2003) · Nature Immunology · doi:10.1038/ni967 · Cited by 576
Qi, M., & Elion, E. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02470 · Cited by 524
Unraveling the mechanisms of manual therapy: modeling an approach
Bialosky, J. E., Beneciuk, J. M., Bishop, M. D., Coronado, R. A., Penza, C. W., Simon, C. B., & George, S. Z. (2018) · Journal of Orthopaedic & Sports Physical Therapy · doi:10.2519/jospt.2018.7476 · Cited by 482
Big opportunities for small molecules in immuno-oncology
Adams, J. L., Smothers, J., Srinivasan, R., & Hoos, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4596 · Cited by 471
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Pollizzi, K. N., & Powell, J. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3701 · Cited by 379
Murine B7-H3 is a negative regulator of T cells
Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2500 · Cited by 368
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 336
Lee, Y.-H., Martin-Orozco, N., Zheng, P., Li, J., Zhang, P., Tan, H., Park, H. J., Jeong, M., Chang, S. H., Kim, B.-S., et al. (2017) · Cell Research · doi:10.1038/cr.2017.90 · Cited by 328
CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
Wang, C., Li, Y., Jia, L., Kim, J. K., Li, J., Deng, P., Zhang, W., Krebsbach, P. H., & Wang, C.-Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.011 · Cited by 304
Theruvath, J., Sotillo, E., Mount, C. W., Graef, C. M., Delaidelli, A., Heitzeneder, S., Labanieh, L., Dhingra, S., Leruste, A., Majzner, R. G., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0821-8 · Cited by 302
Cytochrome c Release and Caspase Activation in Traumatic Axonal Injury
Büki, A., Okonkwo, D. O., Wang, K. K. W., & Povlishock, J. T. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02825.2000 · Cited by 300
Characterization of Mouse and Human B7-H3 Genes
Sun, M., Richards, S., Prasad, D. V. R., Mai, X. M., Rudensky, A., & Dong, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6294 · Cited by 295
Castriconi, R., Dondero, A., Augugliaro, R., Cantoni, C., Carnemolla, B., Sementa, A. R., Negri, F., Conte, R., Corrias, M. V., Moretta, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405025101 · Cited by 294
Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Loo, D., Alderson, R. F., Chen, F. Z., Huang, L., Zhang, W., Gorlatov, S., Burke, S., Ciccarone, V., Li, H., Yang, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0715 · Cited by 284
Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains
Steinberger, P., Majdic, O., Derdak, S. V., Pfistershammer, K., Kirchberger, S., Klauser, C., Zlabinger, G., Pickl, W. F., Stöckl, J., & Knapp, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2352 · Cited by 276
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
Zang, X., Sullivan, P. S., Soslow, R. A., Waitz, R., Reuter, V. E., Wilton, A., Thaler, H. T., Arul, M., Slovin, S. F., Wei, J., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.95 · Cited by 249
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
Yang, S., Wei, W., & Zhao, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41105 · Cited by 233
B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
Shi, T., Ma, Y., Cao, L., Zhan, S., Xu, Y., Fu, F., Liu, C., Zhang, G., Wang, Z., Wang, R., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1549-6 · Cited by 228
Hashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H., & Azuma, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802423105 · Cited by 227
Wang, R., Ma, Y., Zhan, S., Zhang, G., Cao, L., Zhang, X., Shi, T., & Chen, W. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2252-3 · Cited by 216
B7-H3 role in the immune landscape of cancer.
Castellanos, J. R., Purvis, I. J., Labak, C. M., Guda, M. R., Tsung, A. J., Velpula, K. K., & Asuthkar, S. (2017) · Europe PMC (PubMed Central) · Cited by 205
Hofmeyer, K. A., Ray, A., & Zang, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805458105 · Cited by 201
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Egen, J. G., Ouyang, W., & Wu, L. C. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.010 · Cited by 197
Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B., & Zhang, X. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02723.x · Cited by 192
Yang, M., Tang, X., Zhang, Z., Gu, L., Wei, H., Zhao, S., Zhong, K., Mu, M., Huang, C., Jiang, C., et al. (2020) · Theranostics · doi:10.7150/thno.43991 · Cited by 190
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
Nehama, D., Di Ianni, N., Musio, S., Du, H., Patané, M., Pollo, B., Finocchiaro, G., Park, J. J. H., Dunn, D. E., Edwards, D. S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.030 · Cited by 183
B7-H3 in Cancer – Beyond Immune Regulation
Flem-Karlsen, K., Fodstad, Ø., Tan, M., & Nunes-Xavier, C. E. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.03.010 · Cited by 172
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
Yonesaka, K., Haratani, K., Takamura, S., Sakai, H., Kato, R., Takegawa, N., Takahama, T., Tanaka, K., Hayashi, H., Takeda, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2852 · Cited by 167
Lim, S., Liu, H., da Silva, L. M., Arora, R., Liu, Z., Phillips, J. B., Schmitt, D. C., Vu, T., McClellan, S., Lin, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1538 · Cited by 162
B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
Liu, H., Tekle, C., Chen, Y.-W., Kristian, A., Zhao, Y., Zhou, M., Liu, Z., Ding, Y., Wang, B., Mælandsmo, G. M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0072 · Cited by 158
Scribner, J. A., Brown, J. G., Son, T., Chiechi, M., Li, P., Sharma, S., Li, H., De Costa, A., Li, Y., Chen, Y., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0116 · Cited by 158
Davis, Z., Vallera, D. A., Miller, J. S., & Felices, M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.011 · Cited by 150
B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
Arigami, T., Narita, N., Mizuno, R., Nguyen, L., Ye, X., Chung, A. P., Giuliano, A. E., & Hoon, D. S. �. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181f1939d · Cited by 148
Yao, J., Wang, J., Liu, Y., Wang, B., Li, Y., Zhang, R., Wang, L., & Liu, L. (2015) · Medical Oncology · doi:10.1007/s12032-015-0661-4 · Cited by 146
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
Vigdorovich, V. I., Ramagopal, U. A., Lázár‐Molnár, E., Sylvestre, E., Lee, J. S., Hofmeyer, K. A., Zang, X., Nathenson, S. G., & Almo, S. C. (2013) · Structure · doi:10.1016/j.str.2013.03.003 · Cited by 136
Cai, D., Li, J., Liu, D., Hong, S., Qiao, Q., Sun, Q., Li, P., Lyu, N., Sun, T., Xie, S., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0305-2 · Cited by 136
B7‐H3 and Its Role in Antitumor Immunity
Loos, M., Hedderich, D. M., Friess, H., & Kleeff, J. H. (2010) · Journal of Immunology Research · doi:10.1155/2010/683875 · Cited by 123
Apoptosis and colorectal cancer: implications for therapy
Yang, S. Y., Sales, K. M., Fuller, B. J., Seifalian, A. M., & Winslet, M. C. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.03.003 · Cited by 120
Ahmed, M., Cheng, M. H., Zhao, Q., Goldgur, Y., Cheal, S. M., Guo, H.-F., Larson, S. M., & Cheung, N. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679852 · Cited by 117
Xie, C. L., Liu, D., Chen, Q., Yang, C., Wang, B., & Wu, H. (2016) · Scientific Reports · doi:10.1038/srep27528 · Cited by 116
Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
Zhang, T., Jiang, B., Zou, S.-T., Liu, F., & Hua, D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1804 · Cited by 101
Vallera, D. A., Ferrone, S., Kodal, B., Hinderlie, P., Bendzick, L. E., Ettestad, B., Hallstrom, C., Zorko, N. A., Rao, A., Fujioka, N., et al. (2020) · Cancers · doi:10.3390/cancers12092659 · Cited by 100
The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization
Suh, W., Wang, S. X., Jheon, A. H., Moreno, L., Yoshinaga, S. K., Ganss, B., Sodek, J., Grynpas, M. D., & Mak, T. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405259101 · Cited by 96
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
Girardi, T., Vereecke, S., Sulima, S. O., Khan, Y. A., Fancello, L., Briggs, J., Schwab, C. J., de Beeck, J. O., Verbeeck, J., Royaert, J., et al. (2017) · Leukemia · doi:10.1038/leu.2017.225 · Cited by 95
Li, Y., Guo, G., Song, J. Y., Cai, Z., Yang, J., Chen, Z., Wang, Y., Huang, Y., & Gao, Q. (2017) · Journal of Cancer · doi:10.7150/jca.17759 · Cited by 93
Survivin as a novel target protein for reducing the proliferation of cancer cells (Review)
Li, D., Hu, C., & Li, H. (2018) · Biomedical Reports · doi:10.3892/br.2018.1077 · Cited by 92
Tumor-Antigen–Binding Bispecific Antibodies for Cancer Treatment
Weidle, U. H., Kontermann, R. E., & Brinkmann, U. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.08.004 · Cited by 89
B7-H3 promotes gastric cancer cell migration and invasion
Li, Y., Yang, X., Wu, Y., Zhao, K., Ye, Z., Zhu, J., Xu, X., Zhao, X., & Xing, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17847 · Cited by 88
Jiang, B., Zhang, T., Liu, F., Sun, Z., Shi, H., Hua, D., & Yang, C. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9035 · Cited by 87
Nunes‐Xavier, C. E., Karlsen, K. F., Tekle, C., Pedersen, C., Øyjord, T., Hongisto, V., Nesland, J. M., Tan, M., Sahlberg, K. K., & Fodstad, Ø. (2016) · Oncotarget · doi:10.18632/oncotarget.6902 · Cited by 84
MacGregor, H. L., Sayad, A., Elia, A., Wang, B. X., Katz, S. R., Shaw, P. A., Clarke, B. A., Crome, S. Q., Robert-Tissot, C., Bernardini, M. Q., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0816-5 · Cited by 82
B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells
Lu, H., Shi, T., Wang, M., Li, X., Gu, Y., Zhang, X., Zhang, G., & Chen, W. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1748991 · Cited by 82
Small-Molecule Immuno-Oncology Therapy: Advances, Challenges and New Directions
Chen, S., Song, Z., & Zhang, A. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190308131805 · Cited by 81
Karlsen, K. F., Tekle, C., Andersson, Y., Flatmark, K., Fodstad, Ø., & Nunes‐Xavier, C. E. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12599 · Cited by 77
Yang, S., Cao, B., Zhou, G., Zhu, L., Wang, L., Zhang, L., Kwok, H. F., Zhang, Z., & Zhao, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01089 · Cited by 76
Wilson, K. E., Bachawal, S. V., Abou‐Elkacem, L., Jensen, K. C., Machtaler, S., Tian, L., & Willmann, J. K. (2017) · Theranostics · doi:10.7150/thno.18217 · Cited by 72
Tang, X., Liu, F., Liu, Z., Cao, Y. L., Zhang, Z., Wang, Y., Huang, J., Fan, S., Zhao, S., Chen, Y., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1137 · Cited by 71
An Orthotopic Colon Cancer Model for Studying the B7-H3 Antitumor Effect In Vivo
Lupu, C., Eisenbach, C., Kuefner, M. A., Schmidt, J., Lupu, A., Stremmel, W., & Encke, J. (2006) · Journal of Gastrointestinal Surgery · doi:10.1007/bf03239969 · Cited by 68
Lei, X., Ou, Z., Yang, Z., Zhong, J., Zhu, Y., Tian, J., Wu, J., Deng, H., Lin, X., Yu, P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2487 · Cited by 67
Chen, W., Liu, P., Wang, Y., Nie, W., Li, Z., Xu, W., Li, F., Zhou, Z., Zhao, M., & Liu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076965 · Cited by 64
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
Ma, J., Ma, P., Zhao, C., Xue, X., Han, H., Liu, C., Tao, H., Xiu, W., Cai, J., & Zhang, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8784 · Cited by 62
Wang, L., Kang, F., Sun, N., Wang, J., Chen, W., Li, D., & Shan, B. (2016) · Tumor Biology · doi:10.1007/s13277-016-5386-2 · Cited by 60
B7-H3 in tumors: friend or foe for tumor immunity?
Li, G. L., Quan, Y., Che, F., & Wang, L. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3508-1 · Cited by 58
Lupu, C., Eisenbach, C., Lupu, A., Kuefner, M. A., Hoyler, B., Stremmel, W., & Encke, J. (2007) · Oncology Reports · doi:10.3892/or.18.3.745 · Cited by 56
Proctor, D. T., Patel, Z., Lama, S., Resch, L., van Marle, G., & Sutherland, G. R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1512943 · Cited by 55
Expression of CD24 and B7-H3 in breast cancer and the clinical significance
Cong, F., Yu, H., & Gao, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7142 · Cited by 54
Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
Purvis, I. J., Avilala, J., Guda, M. R., Venkataraman, S., Vibhakar, R., Tsung, A. J., Velpula, K. K., & Asuthkar, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081158 · Cited by 53
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
Hage, A., & Dormond, O. (2021) · Cancers · doi:10.3390/cancers13061359 · Cited by 53
B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
Zhang, W., Wang, J., Wang, Y., Dong, F., Zhu, M., Wan, W., Li, H.-S., Wu, F., Yan, X., & Ke, X. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s85272 · Cited by 52
Varki, V., Ioffe, O. B., Bentzen, S. M., Heath, J., Cellini, A., Feliciano, J. L., & Zandberg, D. P. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2138-8 · Cited by 52
Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma
Ling, W., Cao, N., Wang, S., Man, H., Li, P.-F., & Shan, B.-E. (2015) · Tumor Biology · doi:10.1007/s13277-015-4132-5 · Cited by 51
Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy
Minami, Y., Nishida, N., & Kudo, M. (2019) · European Radiology · doi:10.1007/s00330-019-06189-6 · Cited by 51
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Karlsen, K. F., Tekle, C., Øyjord, T., Flørenes, V. A., Mælandsmo, G. M., Fodstad, Ø., & Nunes‐Xavier, C. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-42303-w · Cited by 43
B7-H3 targeted antibody-based immunotherapy of malignant diseases
Michelakos, T. P., Kontos, F., Barakat, O., Maggs, L., Schwab, J. H., Ferrone, C. R., & Ferrone, S. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1862791 · Cited by 43
Aung, P. P., Parra, E. R., Barua, S., Sui, D., Ning, J., Mino, B., Ledesma, D. A., Curry, J. L., Nagarajan, P., Torres-Cabala, C. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2355 · Cited by 42
B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role
Purvis, I. J., Velpula, K. K., Guda, M. R., Nguyen, D., Tsung, A. J., & Asuthkar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197050 · Cited by 37
Li, H., Zhang, B., Liu, Y., & Yin, C. (2014) · Medical Oncology · doi:10.1007/s12032-014-0162-x · Cited by 33
Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer cell lines and glioma tissues
Wang, Z., Yang, J., ZHU, Y., ZHU, Y., Zhang, B., & Zhou, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3611 · Cited by 28
B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration
Hu, X., Xu, M., Hu, Y., Li, N., & Zhou, L. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-00975-0 · Cited by 28
Deng, J., Ma, M., Wang, D., Zhu, H., Hua, L., Sun, S., Chen, H., Cheng, H., Qian, Z. R., Xie, Q. M., et al. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.10.044 · Cited by 27
One Big Step to a Neuron, Two Small Steps for miRNAs
Herdy, J. R., Karbacher, L., & Mertens, J. (2021) · Cell stem cell · doi:10.1016/j.stem.2020.12.007 · Cited by 24
Lu, H., Ma, Y., Wang, M., Shen, J., Wu, H., Li, J., Gao, N., Gu, Y., Zhang, X., Zhang, G., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02771-w · Cited by 22
Xu, Y., Xiao, Y. Z., Luo, C., Liu, Q., Wei, A., Yang, Y., Zhao, L., & Wang, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106584 · Cited by 19
Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling
Li, F., Chen, H., & Wang, D. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.04.41 · Cited by 19
Niu, H., Wu, B., Yang, P., Jiang, H., Zhang, Y., Wang, J., Zhang, Y., & He, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-2671-9 · Cited by 17
White, A., Lee, D. N., Mazzola, E., Kücükak, S., Polhemus, E., Jaklitsch, M. T., Mentzer, S. J., Wee, J. O., Bueno, R., & Swanson, S. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26305 · Cited by 12
Lei, K. F., Ji, W.-W., Goh, A., Huang, C., & Lee, M. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0442-5 · Cited by 7
Scribner, J. A., Brown, J. G., Sharma, S., Li, H., Chiechi, M., Li, P., Son, T., Costa, A. D., Chen, Y., Chen, F., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-820 · Cited by 5
Cited by
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Hu, Y., Dong, Z., & Liu, K. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02949-5 · Cited by 268
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Arafat Hossain, M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113365 · Cited by 178
Xie, Y., Wang, X., Wang, W., Pu, N., & Liu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06422-5 · Cited by 80
“It has been shown to suppress CD8 + T cell activation, proliferation, and cytokine production, diminish NK cell-mediated tumor cell lysis, and increase the infiltration of Tregs [67–69].”
Metadata
- Authors
- Zhou, W.-T., & Jin, W.-L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-07-19
- Volume
- 12
- Pages
- 701006-701006
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3185708072
- Cited by
- 295
- References
- 106
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.